These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Intravitreal aflibercept efficacy in neovascular age-related macular degeneration with suboptimal response to anti-vascular endothelial growth factor-A therapy. Monés J; Biarnés M; Eur J Ophthalmol; 2020 Sep; 30(5):1082-1090. PubMed ID: 31088111 [TBL] [Abstract][Full Text] [Related]
8. REOPENING OF MACULAR HOLE AFTER INTRAVITREAL AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Chan EW; Sun V; Chen JC Retin Cases Brief Rep; 2020; 14(3):255-259. PubMed ID: 29252912 [TBL] [Abstract][Full Text] [Related]
9. Intraoperative and fluorescein angiographic findings of a secondary macular hole associated with age-related macular degeneration treated by pars plana vitrectomy. Okamoto T; Shinoda H; Kurihara T; Nagai N; Tsubota K; Ozawa Y BMC Ophthalmol; 2014 Sep; 14():114. PubMed ID: 25270019 [TBL] [Abstract][Full Text] [Related]
10. Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab. Nudleman E; Wolfe JD; Woodward MA; Yonekawa Y; Williams GA; Hassan TS Clin Ophthalmol; 2016; 10():1053-7. PubMed ID: 27354759 [TBL] [Abstract][Full Text] [Related]
11. Injection frequency and anatomic outcomes 1 year following conversion to aflibercept in patients with neovascular age-related macular degeneration. Messenger WB; Campbell JP; Faridi A; Shippey L; Bailey ST; Lauer AK; Flaxel CJ; Hwang TS Br J Ophthalmol; 2014 Sep; 98(9):1205-7. PubMed ID: 24795334 [TBL] [Abstract][Full Text] [Related]
12. Comparison of intravitreal injections of Ranibizumab and Aflibercept in neovascular age related macular degeneration. Sizmaz S; Esen E; Isik-Ericek P; Demircan N Clin Exp Optom; 2022 Jan; 105(1):55-60. PubMed ID: 33719869 [No Abstract] [Full Text] [Related]
13. A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration. Park DH; Sun HJ; Lee SJ Int Ophthalmol; 2017 Oct; 37(5):1205-1214. PubMed ID: 27826933 [TBL] [Abstract][Full Text] [Related]
14. Retinal and Choroidal Changes after Anti Vascular Endothelial Growth Factor Therapy for Neovascular Age-related Macular Degeneration. Kim SW; Woo JE; Yoon YS; Lee S; Woo JM; Min JK Curr Pharm Des; 2019; 25(2):184-189. PubMed ID: 30892159 [TBL] [Abstract][Full Text] [Related]
15. Tolerating subretinal fluid in the treatment of neovascular age-related macular degeneration with intravitreal aflibercept. Yildiz D; Cakir A; Erden B; Bolukbasi S; Erdenöz S; Elcioglu MN Ther Adv Ophthalmol; 2021; 13():25158414211022874. PubMed ID: 34164606 [TBL] [Abstract][Full Text] [Related]
16. Meticulous multimodal analysis of aflibercept therapy for submacular vascularized pigment epithelial detachment associated with neovascular AMD in a prospective case series, the EVEN study. Chan CK; Sarraf D; Abraham P; Lalezary M; Lin SG; Chen X; Nittala MG; Sadda S Am J Ophthalmol Case Rep; 2020 Dec; 20():100916. PubMed ID: 33024885 [TBL] [Abstract][Full Text] [Related]
17. Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab. Bakall B; Folk JC; Boldt HC; Sohn EH; Stone EM; Russell SR; Mahajan VB Am J Ophthalmol; 2013 Jul; 156(1):15-22.e1. PubMed ID: 23706500 [TBL] [Abstract][Full Text] [Related]
18. Removal of choroidal neovascular membrane in a case of macular hole after anti-VEGF therapy for age-related macular degeneration. Hirata A; Hayashi K; Murata K; Nakamura KI Am J Ophthalmol Case Rep; 2018 Mar; 9():14-17. PubMed ID: 29468210 [TBL] [Abstract][Full Text] [Related]
19. Lamellar macular hole formation following intravitreal bevacizumab injection for choroidal neovascularization by age-related macular degeneration. Torabi H; Jadidi K; Naderi M Oman J Ophthalmol; 2018; 11(3):277-279. PubMed ID: 30505124 [TBL] [Abstract][Full Text] [Related]
20. Switch to aflibercept in the treatment of neovascular age-related macular degeneration: 30-month results. Ertan E; Doğan M; Polat O; Efe N; Akdoğan M; İnan S; Duman R; Duman R Arq Bras Oftalmol; 2021; 84(3):225-229. PubMed ID: 33567025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]